Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.67 USD | +5.96% | +7.24% | -23.95% |
04-02 | Goldman Sachs Initiates Olema Pharmaceuticals at Buy With $24 Price Target | MT |
03-18 | Olema Pharmaceuticals, Inc.(NasdaqGS:OLMA) added to S&P Biotechnology Select Industry Index | CI |
Business Summary
Number of employees: 74
Managers
Managers | Title | Age | Since |
---|---|---|---|
Peter Kushner
FOU | Founder | 86 | 06/08/06 |
Sean Bohen
CEO | Chief Executive Officer | 58 | 31/08/20 |
Cyrus Harmon
FOU | Founder | 54 | 06/08/06 |
Shane Kovacs
DFI | Director of Finance/CFO | 50 | 31/05/20 |
Kristin Lanzi
CTO | Chief Tech/Sci/R&D Officer | - | - |
Naseem Zojwalla
CTO | Chief Tech/Sci/R&D Officer | 51 | 30/01/22 |
Sasha Austin
AUD | Comptroller/Controller/Auditor | - | 31/12/20 |
General Counsel | - | 30/06/22 | |
Julie Dexter
HRO | Human Resources Officer | - | - |
David Myles
PRN | Corporate Officer/Principal | 62 | 31/03/08 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Clark
CHM | Chairman | 62 | 31/07/20 |
J. Garland
BRD | Director/Board Member | 55 | 15/10/23 |
Andy Rappaport
BRD | Director/Board Member | 66 | 31/12/12 |
Cyrus Harmon
FOU | Founder | 54 | 06/08/06 |
Cynthia Butitta
BRD | Director/Board Member | 70 | 31/07/20 |
Sean Bohen
CEO | Chief Executive Officer | 58 | 31/08/20 |
Sandra Horning
BRD | Director/Board Member | 75 | 12/11/20 |
Director/Board Member | 35 | 30/06/18 | |
Yi Larson
BRD | Director/Board Member | 44 | 05/04/21 |
Graham Walmsley
BRD | Director/Board Member | 37 | 29/02/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 56,019,075 | 53,713,335 ( 95.88 %) | 104,334 ( 0.1862 %) | 95.88 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.95% | 597M | |
+25.69% | 47.9B | |
+47.41% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- OLMA Stock
- Company Olema Pharmaceuticals, Inc.